8-K: Centene Reaffirms 2025 Financial Outlook Ahead of UBS Conference

Centene Corporation will present at the UBS 2025 Global Healthcare Conference, reaffirming its full year 2025 financial forecasts including a diluted loss per share not to exceed $(12.85) and adjusted diluted EPS of at least $2.00.

Summary

• Centene Corporation will participate in the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at 10:15 a.m. EST.
• Management will discuss the company's financial outlook, which is consistent with previously-issued full year 2025 GAAP forecast.
• The full year 2025 GAAP diluted loss per share is forecast not to exceed $(12.85).
• The full year 2025 adjusted diluted earnings per share (EPS) forecast is at least $2.00.
• A simultaneous live audio webcast of Centene's participation will be available, with a replay accessible via the company's website under the Investors section.
• The company provides non-GAAP financial measures, excluding items like amortization of acquired intangible assets and acquisition/divestiture related expenses, to help investors assess core operations and performance more consistently.

Sentiment

Score: 6

Explanation: The filing reaffirms previously issued financial guidance, which provides clarity and consistency. While a GAAP loss is projected, the adjusted EPS forecast is positive, indicating a stable outlook for core operations. This is a routine update for an investor conference.

Positives

• Reaffirmation of previously issued financial guidance provides stability and predictability for investors.
• Adjusted diluted EPS forecast of at least $2.00 for full year 2025 indicates positive core operational performance.

Negatives

• GAAP diluted loss per share forecast not to exceed $(12.85) for full year 2025.

Risks

• Ability to design and price competitive and actuarially sound products.
• Ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical costs.
• Rate cuts, insufficient rate changes, or other payment reductions or delays by government payors affecting government businesses.
• Effect of social, economic, and political conditions, geopolitical events, and state and federal policies, including funding for government-sponsored healthcare programs.
• Changes in federal or state laws or regulations, including income tax reform, government healthcare programs, the Patient Protection and Affordable Care Act (ACA), and any regulations thereunder.
• Unanticipated increased healthcare costs, including due to changes in consumer and provider behaviors, inflation, and tariffs.
• Ability to maintain or achieve improvement in Centers for Medicare and Medicaid Services (CMS) Star ratings and other quality scores, which could impact revenue and future growth.
• Competition, including for providers, broker distribution networks, contract reprocurements, and organic growth.
• Ability to adequately anticipate demand and timely provide operational resources to maintain service level requirements.
• Ability to comply with contract terms and state/federal regulations, and effectively oversee third-party vendors.
• Ability to manage information systems effectively.
• Disruption, unexpected costs, or similar risks from business transactions, including acquisitions, divestitures, and changes in third-party vendor relationships.
• Impairments to real estate, investments, goodwill, and intangible assets.
• Changes in senior management, loss of key personnel, or inability to attract, hire, integrate, and retain skilled personnel.
• Membership and revenue declines or unexpected trends.
• Changes in healthcare practices, new technologies, and advances in medicine.
• Ability to effectively and ethically use artificial intelligence and machine learning in compliance with applicable laws.
• Changes in macroeconomic conditions, including inflation, interest rates, and financial market volatility.
• Negative public perception of the Company and the managed care industry.
• Uncertainty concerning government shutdowns, debt ceilings, or funding.
• Tax matters.
• Disasters, climate-related incidents, acts of war or aggression, or major epidemics.
• Changes in expected contract start dates and terms.
• Changes in provider, broker, vendor, state, federal, and other contracts, and delays in regulatory approval of contracts.
• Expiration, suspension, or termination of contracts with federal or state governments.
• Difficulty of predicting the timing or outcome of legal or regulatory audits, investigations, proceedings, or matters.
• Challenges to contract awards.
• Cyber-attacks or other data security incidents or failure to comply with privacy, data, or security laws.
• Exertion of management's time and resources, and other expenses incurred in complying with contract terms and regulatory undertakings.
• Changes in expected closing dates, estimated purchase price, or accretion for acquisitions or dispositions.
• Losses in the investment portfolio.
• Restrictions and limitations in connection with indebtedness.
• A downgrade of corporate family rating, issuer rating, or credit rating of indebtedness.
• Availability of debt and equity financing on favorable terms.

Future Outlook

Centene Corporation's management will discuss its financial outlook at the UBS 2025 Global Healthcare Conference, which remains consistent with its previously issued full year 2025 GAAP diluted loss per share forecast not to exceed $(12.85) and adjusted diluted EPS forecast of at least $2.00. The company emphasizes the use of non-GAAP measures for assessing core operations and performance.

Management Comments

• Members of management will discuss the Company's financial outlook, which is consistent with its previously-issued full year 2025 GAAP forecast of a diluted loss per share not to exceed $(12.85) and full year 2025 adjusted diluted earnings per share (EPS) forecast of at least $2.00.

Industry Context

This announcement is a routine disclosure for a major healthcare company attending an industry-specific investor conference. It signals Centene's continued engagement with the investment community and its commitment to transparency regarding its financial projections within the dynamic managed care sector. The reaffirmation of guidance suggests stability in its operational expectations amidst broader healthcare trends.

Comparison to Industry Standards

• NA The filing only provides forecasts and does not include specific results or projects for direct comparison to industry benchmarks or competitors.

Stakeholder Impact

• Shareholders/Investors: Provides updated financial guidance, aiding investment decisions. Reaffirms previous forecasts, offering predictability.
• Management: Engages with the investment community at a key industry conference, maintaining transparency regarding financial projections.

Next Steps

• Centene Corporation will appear at the UBS 2025 Global Healthcare Conference on November 11, 2025.
• A simultaneous live audio webcast of the conference participation will be available.
• A webcast replay will be available following the presentation via the Company's website.

Key Dates

Recommendation

The filing reaffirms previously issued guidance, indicating no new material information that would significantly alter the investment thesis. The company is maintaining its outlook, which includes a GAAP loss but a positive adjusted EPS. This suggests a stable, but not necessarily rapidly improving, operational environment. Investors should hold and await further developments or actual results.

Keywords

Healthcare, Managed Care, Centene, Financial Outlook, EPS, GAAP, Non-GAAP, SEC Filing, 8-K, Investor Conference, UBS, Healthcare Conference, Stock, Investment, Risk Factors, Guidance